About this book:

Explore the remarkable journey of Merck & Co., a global pharmaceutical giant whose story began as a 17th-century German apothecary and transformed into an independent American powerhouse. This comprehensive narrative delves into Merck's pivotal separation during World War I, its emergence as a leader in scientific discovery, and its relentless pursuit of medical breakthroughs that have redefined global health. From pioneering the mass production of penicillin and discovering life-saving compounds like cortisone and streptomycin, to the revolutionary development of vaccines under Maurice Hilleman, Merck’s commitment to innovation has consistently pushed the boundaries of medicine.

Discover how Merck navigated intense competition, strategic mergers like the one with Sharp & Dohme, and the complex challenges of the 21st century, including the significant Vioxx litigation. The book highlights the company's strategic pivot towards oncology, culminating in the monumental success of Keytruda, a drug that transformed cancer treatment. It also examines Merck's expansive animal health division, its commitment to corporate social responsibility, and its aggressive strategy of acquisitions and diversification to secure future growth in a rapidly evolving healthcare landscape. This in-depth account reveals how Merck & Co. continues to leverage cutting-edge science, ethical leadership, and a global reach to address humanity's most pressing health challenges, ensuring its enduring legacy in improving lives worldwide.

What You'll Find Inside:

• Merck's Transformation: Explore how Merck & Co. evolved from a German apothecary's American subsidiary to a fully independent U.S. pharmaceutical giant after World War I, shaping its unique global identity.
• Pioneering Drug Discovery: Discover Merck's groundbreaking contributions to medicine, including the development of life-saving drugs like cortisone, statins (Mevacor/Zocor), and innovative antibiotics (Streptomycin, Imipenem).
• Vaccine Revolution: Learn about Maurice Hilleman's unparalleled impact at Merck, leading to the development of critical vaccines such as MMR (measles, mumps, rubella), Hepatitis B, and the cancer-preventing HPV vaccine (Gardasil).
• Strategic Business Evolution: Understand Merck's bold strategic shifts, including its controversial entry into pharmacy benefit management with Medco and its targeted acquisitions to diversify and strengthen its pipeline.
• The Keytruda Success Story: Delve into the development and monumental commercial success of Keytruda, a transformative cancer immunotherapy, and Merck's strategic efforts to diversify its portfolio ahead of its patent expiration.

Who's It For:

This book is essential reading for anyone interested in the history of medicine, pharmaceutical innovation, and American business. It will particularly appeal to healthcare professionals, business students, investors in the biotechnology sector, and individuals curious about the ethical and scientific challenges faced by leading global corporations in their pursuit of improving human health.